In conclusion, we showed that the production of full-length TRAIL by an adenoviral vector effectively kills NSCLC H460 cells that can be enhanced by combined treatment with the chemotherapeutic agents CDDP, DOX and PTX and by radiation. This evidence concerns the gene TNFSF10 and non-small cell lung carcinoma.